Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

COAGULATION FACTOR VIIA RECOMBINANT HUMAN for Postpartum haemorrhage: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where COAGULATION FACTOR VIIA RECOMBINANT HUMAN was used for Postpartum haemorrhage.

Most Reported Side Effects for COAGULATION FACTOR VIIA RECOMBINANT HUMAN

Side Effect Reports % Deaths Hosp.
Off label use 169 17.8% 85 50
Haemorrhage 129 13.6% 21 53
Drug ineffective 117 12.3% 26 47
Death 85 8.9% 85 8
Pre-existing disease 78 8.2% 78 22
Therapy partial responder 78 8.2% 76 23
Acquired haemophilia 72 7.6% 70 23
Haemarthrosis 47 4.9% 3 27
Haematoma 30 3.2% 3 21
Therapy responder 30 3.2% 27 22
Thrombosis 27 2.8% 6 12
Condition aggravated 23 2.4% 8 11
Shock haemorrhagic 20 2.1% 14 8
Epistaxis 19 2.0% 0 13
Haemorrhage intracranial 19 2.0% 7 8

Other Indications for COAGULATION FACTOR VIIA RECOMBINANT HUMAN

Acquired haemophilia (244) Factor viii deficiency (130) Product used for unknown indication (97) Haemorrhage (92) Prophylaxis (54) Factor vii deficiency (51) Haemophilia (44) Haemophilia a with anti factor viii (43) Factor ix deficiency (36) Haemostasis (30)

Other Drugs Used for Postpartum haemorrhage

CARBOPROST TROMETHAMINE (199) TRANEXAMIC ACID (67) OXYTOCIN (62) MISOPROSTOL (43) METHYLERGONOVINE (24) OXYTOCIN\SODIUM (19) FIBRINOGEN HUMAN (17) CARBOPROST (15) ERGONOVINE (15) SULPROSTONE (11)

Related Pages

COAGULATION FACTOR VIIA RECOMBINANT HUMAN Full Profile All Postpartum haemorrhage Drugs COAGULATION FACTOR VIIA RECOMBINANT HUMAN Demographics COAGULATION FACTOR VIIA RECOMBINANT HUMAN Timeline